NBP — NovaBridge Biosciences Share News
0.000.00%
Last trade - 00:00- $158.92m
- -$31.93m
U.S. STOCKS ON THE MOVE-Take-Two, RedHill Biopharma, Gold Miners,
U.S. STOCKS ON THE MOVE-Target, Bed Bath & Beyond, Hill International, Low's
I-Mab falls as AbbVie scraps blood cancer therapy trial
Brief: I-Mab Doses Patient In Phase 1 Clinical Trial Of Claudin 18.2, 4-1BB Bispecific Antibody TJ-CD4B In Solid Tumors
Brief: I-Mab To Present Phase 2 Clinical Data Of CD47 Antibody Lemzoparlimab
Brief: I-Mab Partner Morphosys Announces New License Agreements For Felzartamab And Tj210
U.S. STOCKS ON THE MOVE-Chinese ADRs, DexCom, Mullen Automotive
I-Mab up on completing enrollment for pediatric therapy study
Brief: I-Mab Announces Completion Of Patient Enrollment In Phase III Clinical Trial Of Eftansomatropin Alfa
Brief: I-Mab Reports Latest Phase 2 Clinical Data Of Its Differentiated Cd73 Antibody Uliledlimab
Brief: I-Mab Provides Updates On Status Under Holding Foreign Companies Accountable Act
U.S. STOCKS ON THE MOVE-OpGen Inc, Anthem Inc, Dow Inc
U.S. STOCKS ON THE MOVE-Procter & Gamble, AlloVir, Netflix
I-Mab surges after Bloomberg report on biotech exploring options
Media: Chinese biotech I-Mab weighing options including sale - Bloomberg News
Brief: I-Mab Announces Voluntary Lock-Ups By Key Shareholders, Management For Long-Term Commitment
Brief: Tasly Pharma's 2021 Net Profit Up 109.5% Y/Y
Brief: I-Mab Provides Business And Corporate Updates
I-Mab expected to post a loss of 48 cents a share - Earnings Preview